Saxenda does produce meaningful weight loss, though the results are more modest than what newer medications on the market can achieve. In long-term clinical trials lasting about three years, people taking Saxenda lost an average of 6.1% of their body weight, compared to 1.9% with a placebo. Roughly half of all patients lost at least 5% of their starting weight, and about one in four lost more than 10%.
How Saxenda Causes Weight Loss
Saxenda is a daily injection of liraglutide, a synthetic version of a hormone your body already makes called GLP-1. This hormone is released naturally after you eat, and it plays a key role in regulating appetite and food intake. Saxenda mimics GLP-1 with over 95% structural similarity to the natural version, but it lasts much longer in your body.
The medication works through two main pathways. First, it acts on the appetite center in your brain to reduce hunger and increase feelings of fullness after meals. Second, it slows the rate at which your stomach empties, so food stays in your digestive system longer and you feel satisfied with less. The combined effect is that you simply eat less without feeling like you’re white-knuckling your way through a diet. The weight loss comes from reduced calorie intake, not from burning extra calories or blocking fat absorption.
What the Weight Loss Numbers Look Like
The most robust data comes from the large SCALE clinical trial program. At 56 weeks (about one year), patients typically lose in the range of 5 to 8% of their body weight. The longer-term data, extending out to week 160 (roughly three years), showed an average loss of 6.1% of body weight. That number reflects the reality that some early weight regain can occur even while still on the medication, as initial losses tend to be the steepest.
To put that in practical terms: if you weigh 220 pounds, a 6% loss is about 13 pounds. A 10% loss, which about a quarter of patients achieved, would be 22 pounds. These numbers may sound underwhelming if you’ve seen headlines about newer drugs, but even a 5 to 10% reduction in body weight produces real improvements in blood pressure, blood sugar, cholesterol, and joint pain.
Saxenda vs. Wegovy
This is where context matters. Wegovy (semaglutide) is a newer, once-weekly GLP-1 medication that has largely overtaken Saxenda in popularity, and the reason is straightforward: it works significantly better. In a head-to-head comparison at 68 weeks, people on Wegovy lost an average of 15.8% of their body weight versus 6.4% on Saxenda. Among people with weight-related health conditions like high blood pressure or type 2 diabetes, the gap was similar: 14.9% with Wegovy compared to 7.4% with Saxenda.
Saxenda still has a place for people who can’t tolerate or access semaglutide, but if pure weight loss efficacy is the goal, the evidence favors Wegovy by a wide margin. Saxenda also requires a daily injection rather than a weekly one, which some people find less convenient.
Common Side Effects
Digestive issues are the most frequent side effects, and they’re common enough that the medication uses a gradual dose increase over five weeks specifically to reduce their severity. In clinical trials:
- Nausea: 39% of Saxenda users (vs. 14% on placebo)
- Diarrhea: 21% (vs. 10% on placebo)
- Constipation: 19% (vs. 9% on placebo)
- Vomiting: 16% (vs. 4% on placebo)
Nausea is the most talked-about side effect and the one most likely to make people quit early. It tends to be worst during the first few weeks of dose increases and often improves as your body adjusts. Eating smaller meals, avoiding fatty foods, and staying hydrated can help. For most people, these side effects are manageable, but a meaningful percentage do discontinue because of them.
Saxenda also carries a boxed warning (the FDA’s most serious type) regarding thyroid tumors. In animal studies, liraglutide caused thyroid C-cell tumors in rats and mice. Whether this translates to humans is unknown. The medication is contraindicated if you have a personal or family history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2. Symptoms to be aware of include a lump in your neck, difficulty swallowing, or persistent hoarseness.
The Dose Ramp-Up Schedule
You don’t start at the full dose. Saxenda uses a five-week titration designed to let your body adjust gradually and reduce nausea. You begin at 0.6 mg daily in week one, increase to 1.2 mg in week two, 1.8 mg in week three, 2.4 mg in week four, and reach the maintenance dose of 3.0 mg from week five onward. Each dose is a once-daily injection you give yourself under the skin of your abdomen, thigh, or upper arm using a prefilled pen.
What Happens When You Stop
This is one of the most important things to understand about Saxenda, and weight loss medications in general. Weight consistently rebounds after stopping. A large meta-analysis published in The Lancet found that at one year after stopping GLP-1 medications, people had regained about 60% of the weight they lost during treatment. The regain eventually plateaus at roughly 75% of the lost weight, meaning some benefit persists, but most of the progress reverses.
The pattern is predictable: regain is fastest in the first few months, then gradually slows. The “half-life” of weight regain is about 23 weeks, meaning half the lost weight typically returns within about five and a half months after stopping. This doesn’t mean the medication failed. It means obesity is a chronic condition, and the medication works by continuously suppressing appetite. Remove the medication, and the underlying biology reasserts itself. Many prescribers frame Saxenda as a long-term or indefinite treatment for this reason.
Who Can Get a Prescription
Saxenda is FDA-approved for adults with a BMI of 30 or higher (obesity), or a BMI of 27 to 29.9 (overweight) if you also have at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol. It’s also approved for adolescents aged 12 and older who weigh more than 132 pounds (60 kg) and have obesity. In all cases, it’s meant to be used alongside a reduced-calorie diet and increased physical activity, not as a standalone fix.
Cost Considerations
Saxenda has a list price of $1,349.02 for a 30-day supply, which puts it out of reach for many people paying out of pocket. Insurance coverage varies widely. The manufacturer, Novo Nordisk, offers a savings card that can bring the cost down to as little as $25 per prescription or save up to $200 per fill for up to 12 months, though eligibility restrictions apply. If you’re comparing costs, it’s worth checking whether your insurance covers Saxenda, Wegovy, or neither, as coverage often dictates which medication you end up on regardless of clinical preference.
Practical Tips for Using the Pen
Unused Saxenda pens need to be stored in the refrigerator between 2°C and 8°C (36°F to 46°F). Once you start using a pen, you can keep it at room temperature (below 86°F) or in the fridge for up to one month. After 30 days, discard the pen even if there’s medication left in it. Never freeze the pens, and keep them away from direct heat or sunlight. The injection itself takes just a few seconds and uses a small, thin needle that most people find tolerable after the first couple of uses.